BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27784127)

  • 1. CD44 as a Potential Screening Marker for Preliminary Differentiation Between Congenital Dyserythropoietic Anemia Type II and Hereditary Spherocytosis.
    Singleton BK; Ahmed M; Green CA; Heimpel H; Woźniak MJ; Ranjha L; Seeney F; Bomford A; Mehta P; Guest A; Mushens R; King MJ
    Cytometry B Clin Cytom; 2018 Mar; 94(2):312-326. PubMed ID: 27784127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital dyserythropoietic anemia type II (CDAII) is caused by mutations in the SEC23B gene.
    Bianchi P; Fermo E; Vercellati C; Boschetti C; Barcellini W; Iurlo A; Marcello AP; Righetti PG; Zanella A
    Hum Mutat; 2009 Sep; 30(9):1292-8. PubMed ID: 19621418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital dyserythropoietic anemia type II: molecular analysis and expression of the SEC23B gene.
    Punzo F; Bertoli-Avella AM; Scianguetta S; Della Ragione F; Casale M; Ronzoni L; Cappellini MD; Forni G; Oostra BA; Perrotta S
    Orphanet J Rare Dis; 2011 Dec; 6():89. PubMed ID: 22208203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel form of congenital dyserythropoietic anemia associated with deficiency of erythroid CD44 and a unique blood group phenotype [In(a-b-), Co(a-b-)].
    Parsons SF; Jones J; Anstee DJ; Judson PA; Gardner B; Wiener E; Poole J; Illum N; Wickramasinghe SN
    Blood; 1994 Feb; 83(3):860-8. PubMed ID: 7507739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis.
    King MJ; Telfer P; MacKinnon H; Langabeer L; McMahon C; Darbyshire P; Dhermy D
    Cytometry B Clin Cytom; 2008 Jul; 74(4):244-50. PubMed ID: 18454487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved harmonization of eosin-5-maleimide binding test across different instruments and age groups.
    Agarwal AM; Liew MA; Nussenzveig RH; Sangle N; Heikal N; Yaish H; Christensen R
    Cytometry B Clin Cytom; 2016 Nov; 90(6):512-516. PubMed ID: 26384602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of eosin-5-maleimide flow cytometric test in diagnosis of hereditary spherocytosis.
    Kar R; Mishra P; Pati HP
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 2):8-16. PubMed ID: 18782334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delay in the measurement of eosin-5′-maleimide (EMA) binding does not affect the test result for the diagnosis of hereditary spherocytosis.
    Ciepiela O; Kotuła I; Górska E; Stelmaszczyk-Emmel A; Popko K; Szmydki-Baran A; Adamowicz-Salach A; Demkow U
    Clin Chem Lab Med; 2013 Apr; 51(4):817-23. PubMed ID: 23023797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in laboratory diagnosis of hereditary spherocytosis.
    Farias MG
    Clin Chem Lab Med; 2017 Jun; 55(7):944-948. PubMed ID: 27837594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosin-5-maleimide binding to band 3 and Rh-related proteins forms the basis of a screening test for hereditary spherocytosis.
    King MJ; Smythe JS; Mushens R
    Br J Haematol; 2004 Jan; 124(1):106-13. PubMed ID: 14675415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II.
    Schwarz K; Iolascon A; Verissimo F; Trede NS; Horsley W; Chen W; Paw BH; Hopfner KP; Holzmann K; Russo R; Esposito MR; Spano D; De Falco L; Heinrich K; Joggerst B; Rojewski MT; Perrotta S; Denecke J; Pannicke U; Delaunay J; Pepperkok R; Heimpel H
    Nat Genet; 2009 Aug; 41(8):936-40. PubMed ID: 19561605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical, Cellular, and Proteomic Characterization of Hereditary Spherocytosis Among Tunisians.
    Trabelsi N; Bouguerra G; Haddad F; Ouederni M; Darragi I; Boudrigua I; Chaouachi D; Barmat M; Fouzai C; Bejaoui M; Menif S; Kraiem I; Abbes S
    Cell Physiol Biochem; 2021 Mar; 55(1):117-129. PubMed ID: 33667330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital dyserythropoietic anemia type II mimicking hereditary spherocytosis in Indian patient with SEC23B-Y462C mutations.
    Kedar P; Parmar V; Devendra R; Gupta V; Warang P; Madkaikar M
    Ann Hematol; 2017 Dec; 96(12):2135-2139. PubMed ID: 28879554
    [No Abstract]   [Full Text] [Related]  

  • 14. Flow-cytometric analysis of erythrocytes and reticulocytes in congenital dyserythropoietic anaemia type II (CDA II): value in differential diagnosis with hereditary spherocytosis.
    Danise P; Amendola G; Nobili B; Perrotta S; Miraglia Del Giudice E; Matarese SM; Iolascon A; Brugnara C
    Clin Lab Haematol; 2001 Feb; 23(1):7-13. PubMed ID: 11422224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric osmotic fragility test and eosin-5'-maleimide dye-binding tests are better than conventional osmotic fragility tests for the diagnosis of hereditary spherocytosis.
    Arora RD; Dass J; Maydeo S; Arya V; Radhakrishnan N; Sachdeva A; Kotwal J; Bhargava M
    Int J Lab Hematol; 2018 Jun; 40(3):335-342. PubMed ID: 29573337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of the degree of band 3 protein absence on erythrocyte membrane by eosin-5'-maleimide binding test and clinical phenotype in hereditary spherocytosis].
    Peng GX; Yang WR; Jing LP; Zhang L; Zhou K; Li Y; Ye L; Li Y; Li JP; Fan HH; Song L; Zhao X; Wu ZJ; Yang Y; Xiong YZ; Wang HJ; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2017 Jun; 38(6):537-541. PubMed ID: 28655100
    [No Abstract]   [Full Text] [Related]  

  • 17. Toward the harmonization of result presentation for the eosin-5'-maleimide binding test in the diagnosis of hereditary spherocytosis.
    Hunt L; Greenwood D; Heimpel H; Noel N; Whiteway A; King MJ
    Cytometry B Clin Cytom; 2015 Jan; 88(1):50-7. PubMed ID: 25227211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cisternae decorating the red blood cell membrane in congenital dyserythropoietic anemia (type II) originate from the endoplasmic reticulum.
    Alloisio N; Texier P; Denoroy L; Berger C; Miraglia del Giudice E; Perrotta S; Iolascon A; Gilsanz F; Berger G; Guichard J
    Blood; 1996 May; 87(10):4433-9. PubMed ID: 8639805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening and confirmation of hereditary spherocytosis in children using a CELL-DYN Sapphire haematology analyser.
    Rooney S; Hoffmann JJ; Cormack OM; McMahon C
    Int J Lab Hematol; 2015 Feb; 37(1):98-104. PubMed ID: 24739214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early postnatal diagnosis of hereditary spherocytosis by combining light microscopy, acidified glycerol lysis test and eosin-5'-maleimide binding assay.
    Andres O; Eber S; Speer CP
    Ann Hematol; 2015 Dec; 94(12):1959-64. PubMed ID: 26336967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.